Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Novartis Has A New Goal: $2bn Peak Sales Per Product

Nov 28 2023

• By Jessica Merrill

Narrow — Novartis is narrowing its pipeline focus to prioritize higher value assets • Source: Shutterstock

Related Content

Novartis Changing Of The Guard Continues As R&D Chief Bradner Exits

Sep 01 2022

New Pure Play Novartis Vows To Up Its Game – With Help From In-House Challenger Ronny Gal

Sep 22 2022

Sandoz Stands Alone As It Completes Novartis Spinoff

Oct 04 2023

Novartis Bookends October With Two IgAN Successes

Oct 30 2023

Novartis Culls Pipeline As ‘Pure-Play’ Drive Progresses

Apr 25 2023

Related Companies

Novartis AG

Merck & Co., Inc.

Additional Topics

Research & Development Business Strategies Leadership BioPharmaceutical

More from R&D

More from Scrip

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window